533 related articles for article (PubMed ID: 16511603)
1. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
[TBL] [Abstract][Full Text] [Related]
2. Core erythropoietin receptor signals for late erythroblast development.
Menon MP; Fang J; Wojchowski DM
Blood; 2006 Apr; 107(7):2662-72. PubMed ID: 16332976
[TBL] [Abstract][Full Text] [Related]
3. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.
Li K; Menon MP; Karur VG; Hegde S; Wojchowski DM
Blood; 2003 Nov; 102(9):3147-53. PubMed ID: 12869513
[TBL] [Abstract][Full Text] [Related]
4. EPO receptor circuits for primary erythroblast survival.
Sathyanarayana P; Dev A; Fang J; Houde E; Bogacheva O; Bogachev O; Menon M; Browne S; Pradeep A; Emerson C; Wojchowski DM
Blood; 2008 Jun; 111(11):5390-9. PubMed ID: 18349318
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
Miller CP; Heilman DW; Wojchowski DM
Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
[TBL] [Abstract][Full Text] [Related]
6. EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts.
Fang J; Menon M; Kapelle W; Bogacheva O; Bogachev O; Houde E; Browne S; Sathyanarayana P; Wojchowski DM
Blood; 2007 Oct; 110(7):2361-70. PubMed ID: 17548578
[TBL] [Abstract][Full Text] [Related]
7. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit.
Li K; Miller C; Hegde S; Wojchowski D
J Biol Chem; 2003 Oct; 278(42):40702-9. PubMed ID: 12909618
[TBL] [Abstract][Full Text] [Related]
8. Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities.
Porpiglia E; Hidalgo D; Koulnis M; Tzafriri AR; Socolovsky M
PLoS Biol; 2012 Aug; 10(8):e1001383. PubMed ID: 22969412
[TBL] [Abstract][Full Text] [Related]
9. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
10. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin modulation of podocalyxin and a proposed erythroblast niche.
Sathyanarayana P; Menon MP; Bogacheva O; Bogachev O; Niss K; Kapelle WS; Houde E; Fang J; Wojchowski DM
Blood; 2007 Jul; 110(2):509-18. PubMed ID: 17403918
[TBL] [Abstract][Full Text] [Related]
12. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
[TBL] [Abstract][Full Text] [Related]
13. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
[TBL] [Abstract][Full Text] [Related]
14. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.
Socolovsky M; Nam H; Fleming MD; Haase VH; Brugnara C; Lodish HF
Blood; 2001 Dec; 98(12):3261-73. PubMed ID: 11719363
[TBL] [Abstract][Full Text] [Related]
15. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
[TBL] [Abstract][Full Text] [Related]
17. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
18. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.
Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R
Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084
[TBL] [Abstract][Full Text] [Related]
19. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR.
Dolznig H; Grebien F; Deiner EM; Stangl K; Kolbus A; Habermann B; Kerenyi MA; Kieslinger M; Moriggl R; Beug H; Müllner EW
Oncogene; 2006 May; 25(20):2890-900. PubMed ID: 16407844
[TBL] [Abstract][Full Text] [Related]
20. Impaired erythropoiesis in transgenic mice overexpressing a truncated erythropoietin receptor.
Nakamura Y; Takano H; Osawa M; Tomita T; Kim DK; Kojima M; Motohashi T; Miyoshi S; Hiroyama T; Tokumoto Y; Nakauchi H
Exp Hematol; 1998 Nov; 26(12):1105-10. PubMed ID: 9808048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
